Paper36932309
Comparative effects of curcumin versus nano-curcumin on histological, immunohistochemical expression, histomorphometric, and biochemical changes to pancreatic beta cells and lipid profile of streptozocin induced diabetes in male Sprague-Dawley rats.
Metawea MR and 4 others. Environ Sci Pollut Res Int, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Comparative effects of curcumin versus nano-curcumin on histological, immunohistochemical expression, histomorphometric, and biochemical changes to pancreatic beta cells and lipid profile of streptozocin induced diabetes in male Sprague-Dawley rats. Papers, record 36932309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36932309
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Comparative effects of curcumin versus nano-curcumin on histological, immunohistochemical expression, histomorphometric, and biochemical changes to pancreatic beta cells and lipid profile of streptozocin induced diabetes in male Sprague-Dawley rats.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin-Secreting Cells | Major topic |
| Curcumin | Major topic |
| Diabetes Mellitus, Experimental | Major topic |
| Animals | |
| Rats | |
| Male | |
| Blood Glucose | |
| Streptozocin | |
| Rats, Sprague-Dawley | |
| Rats, Wistar | |
| Insulin | |
| Lipids |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42629365 | Ameliorative effect of curcumin and/or cerium oxide nanoparticles on diabetes of rats: biochemical, molecular, and pathological insights. | Sci Rep | 2026 | https://conductscience.org/library/papers/42629365 | PubMed |
| 42016235 | Obesity and Natural Products: Mechanisms, Therapeutic Potential, and Future Directions. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42016235 | PubMed |
| 41999101 | Aqueous Extract of Opuntia ficus-indica (L. Mill) Cladodes Demonstrates Antidiabetic Effect in Normoglycemic and STZ-Induced Diabetic Rats. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/41999101 | PubMed |
| 41093961 | The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. | Sci Rep | 2025 | https://conductscience.org/library/papers/41093961 | PubMed |
| 41074043 | Small extracellular vesicles produced from canine adipose-derived mesenchymal stem cells mitigate diabetes mellitus in streptozotocin-induced mice via β-cell revitalization. | BMC Vet Res | 2025 | https://conductscience.org/library/papers/41074043 | PubMed |
| 41007669 | Nanoparticle-Delivered Rutin Prevents Metabolic and Oxidative Imbalance in Obesity Triggered by a High-Fat Diet: In Vivo and In Silico Studies. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007669 | PubMed |
| 40849768 | Nano-curcumin for the Treatment and Management of Diabetes Mellitus. | Curr Diabetes Rev | 2026 | https://conductscience.org/library/papers/40849768 | PubMed |
| 39539448 | Evening primrose oil ameliorates tissue architecture, apoptosis, and oxidative stress in the pancreas of diabetic rats: Possible role of miR-21. | Iran J Basic Med Sci | 2024 | https://conductscience.org/library/papers/39539448 | PubMed |
| 39251461 | Therapeutic effect of targeted antioxidant natural products. | Discov Nano | 2024 | https://conductscience.org/library/papers/39251461 | PubMed |
| 38998710 | Nanocurcumin-Based Sugar-Free Formulation: Development and Impact on Diabetes and Oxidative Stress Reduction. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38998710 | PubMed |
| 38084125 | Nanocurcumin Reduces High Glucose and Particulate Matter-Induced Endothelial Inflammation: Mitochondrial Function and Involvement of miR-221/222. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/38084125 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36932309
GET https://conductscience.org/api/papers/v1/36932309/authors